2025-01-012025-12-312025-12-31false10941882FORTE ORGANICS LTD2026-09-3020420falseiso4217:GBPxbrli:pure109418822024-12-31109418822025-12-31109418822025-01-012025-12-31109418822023-12-31109418822024-12-31109418822024-01-012024-12-3110941882bus:SmallEntities2025-01-012025-12-3110941882bus:AuditExempt-NoAccountantsReport2025-01-012025-12-3110941882bus:FullAccounts2025-01-012025-12-3110941882bus:PrivateLimitedCompanyLtd2025-01-012025-12-3110941882core:WithinOneYear2025-12-3110941882core:AfterOneYear2025-12-3110941882core:WithinOneYear2024-12-3110941882core:AfterOneYear2024-12-3110941882core:ShareCapital2025-12-3110941882core:SharePremium2025-12-3110941882core:RevaluationReserve2025-12-3110941882core:OtherReservesSubtotal2025-12-3110941882core:RetainedEarningsAccumulatedLosses2025-12-3110941882core:ShareCapital2024-12-3110941882core:SharePremium2024-12-3110941882core:RevaluationReserve2024-12-3110941882core:OtherReservesSubtotal2024-12-3110941882core:RetainedEarningsAccumulatedLosses2024-12-3110941882core:LandBuildings2025-12-3110941882core:PlantMachinery2025-12-3110941882core:Vehicles2025-12-3110941882core:FurnitureFittings2025-12-3110941882core:OfficeEquipment2025-12-3110941882core:NetGoodwill2025-12-3110941882core:IntangibleAssetsOtherThanGoodwill2025-12-3110941882core:ListedExchangeTraded2025-12-3110941882core:UnlistedNon-exchangeTraded2025-12-3110941882core:LandBuildings2024-12-3110941882core:PlantMachinery2024-12-3110941882core:Vehicles2024-12-3110941882core:FurnitureFittings2024-12-3110941882core:OfficeEquipment2024-12-3110941882core:NetGoodwill2024-12-3110941882core:IntangibleAssetsOtherThanGoodwill2024-12-3110941882core:ListedExchangeTraded2024-12-3110941882core:UnlistedNon-exchangeTraded2024-12-3110941882core:LandBuildings2025-01-012025-12-3110941882core:PlantMachinery2025-01-012025-12-3110941882core:Vehicles2025-01-012025-12-3110941882core:FurnitureFittings2025-01-012025-12-3110941882core:OfficeEquipment2025-01-012025-12-3110941882core:NetGoodwill2025-01-012025-12-3110941882core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3110941882core:ListedExchangeTraded2025-01-012025-12-3110941882core:UnlistedNon-exchangeTraded2025-01-012025-12-3110941882core:MoreThanFiveYears2025-01-012025-12-3110941882core:Non-currentFinancialInstruments2025-12-3110941882core:Non-currentFinancialInstruments2024-12-3110941882dpl:CostSales2025-01-012025-12-3110941882dpl:DistributionCosts2025-01-012025-12-3110941882core:LandBuildings2025-01-012025-12-3110941882core:PlantMachinery2025-01-012025-12-3110941882core:Vehicles2025-01-012025-12-3110941882core:FurnitureFittings2025-01-012025-12-3110941882core:OfficeEquipment2025-01-012025-12-3110941882dpl:AdministrativeExpenses2025-01-012025-12-3110941882core:NetGoodwill2025-01-012025-12-3110941882core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3110941882dpl:GroupUndertakings2025-01-012025-12-3110941882dpl:ParticipatingInterests2025-01-012025-12-3110941882dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-012025-12-3110941882core:ListedExchangeTraded2025-01-012025-12-3110941882dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-012025-12-3110941882core:UnlistedNon-exchangeTraded2025-01-012025-12-3110941882dpl:CostSales2024-01-012024-12-3110941882dpl:DistributionCosts2024-01-012024-12-3110941882core:LandBuildings2024-01-012024-12-3110941882core:PlantMachinery2024-01-012024-12-3110941882core:Vehicles2024-01-012024-12-3110941882core:FurnitureFittings2024-01-012024-12-3110941882core:OfficeEquipment2024-01-012024-12-3110941882dpl:AdministrativeExpenses2024-01-012024-12-3110941882core:NetGoodwill2024-01-012024-12-3110941882core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3110941882dpl:GroupUndertakings2024-01-012024-12-3110941882dpl:ParticipatingInterests2024-01-012024-12-3110941882dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3110941882core:ListedExchangeTraded2024-01-012024-12-3110941882dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3110941882core:UnlistedNon-exchangeTraded2024-01-012024-12-3110941882core:NetGoodwill2025-12-3110941882core:IntangibleAssetsOtherThanGoodwill2025-12-3110941882core:LandBuildings2025-12-3110941882core:PlantMachinery2025-12-3110941882core:Vehicles2025-12-3110941882core:FurnitureFittings2025-12-3110941882core:OfficeEquipment2025-12-3110941882core:AfterOneYear2025-12-3110941882core:WithinOneYear2025-12-3110941882core:ListedExchangeTraded2025-12-3110941882core:UnlistedNon-exchangeTraded2025-12-3110941882core:ShareCapital2025-12-3110941882core:SharePremium2025-12-3110941882core:RevaluationReserve2025-12-3110941882core:OtherReservesSubtotal2025-12-3110941882core:RetainedEarningsAccumulatedLosses2025-12-3110941882core:NetGoodwill2024-12-3110941882core:IntangibleAssetsOtherThanGoodwill2024-12-3110941882core:LandBuildings2024-12-3110941882core:PlantMachinery2024-12-3110941882core:Vehicles2024-12-3110941882core:FurnitureFittings2024-12-3110941882core:OfficeEquipment2024-12-3110941882core:AfterOneYear2024-12-3110941882core:WithinOneYear2024-12-3110941882core:ListedExchangeTraded2024-12-3110941882core:UnlistedNon-exchangeTraded2024-12-3110941882core:ShareCapital2024-12-3110941882core:SharePremium2024-12-3110941882core:RevaluationReserve2024-12-3110941882core:OtherReservesSubtotal2024-12-3110941882core:RetainedEarningsAccumulatedLosses2024-12-3110941882core:NetGoodwill2023-12-3110941882core:IntangibleAssetsOtherThanGoodwill2023-12-3110941882core:LandBuildings2023-12-3110941882core:PlantMachinery2023-12-3110941882core:Vehicles2023-12-3110941882core:FurnitureFittings2023-12-3110941882core:OfficeEquipment2023-12-3110941882core:AfterOneYear2023-12-3110941882core:WithinOneYear2023-12-3110941882core:ListedExchangeTraded2023-12-3110941882core:UnlistedNon-exchangeTraded2023-12-3110941882core:ShareCapital2023-12-3110941882core:SharePremium2023-12-3110941882core:RevaluationReserve2023-12-3110941882core:OtherReservesSubtotal2023-12-3110941882core:RetainedEarningsAccumulatedLosses2023-12-3110941882core:AfterOneYear2025-01-012025-12-3110941882core:WithinOneYear2025-01-012025-12-3110941882core:Non-currentFinancialInstrumentscore:CostValuation2025-01-012025-12-3110941882core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-012025-12-3110941882core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-012025-12-3110941882core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-012025-12-3110941882core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-012025-12-3110941882core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-012025-12-3110941882core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3110941882core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3110941882core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3110941882core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3110941882core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-3110941882core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-3110941882core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-3110941882core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-3110941882core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-3110941882core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-12-3110941882core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-3110941882core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-3110941882core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3110941882core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3110941882core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3110941882core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3110941882core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3110941882core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3110941882core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3110941882core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3110941882core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3110941882bus:Director12025-01-012025-12-3110941882bus:Director22025-01-012025-12-3110941882bus:Director32025-01-012025-12-311094188212025-01-012025-12-31

FORTE ORGANICS LTD

Registered Number
10941882
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2025

FORTE ORGANICS LTD
Company Information
for the year from 1 January 2025 to 31 December 2025

Directors

ALEARDI, Courtney
FORTE, Irene Alisea
JONES, Barry

Registered Address

22 Chancery Lane
London
WC2A 1LS

Registered Number

10941882 (England and Wales)
FORTE ORGANICS LTD
Balance Sheet as at
31 December 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets310,04925,259
Tangible assets42,5891,966
Investments520,77320,773
33,41147,998
Current assets
Stocks6864,7031,058,020
Debtors7786,475594,971
Cash at bank and on hand105,889695,799
1,757,0672,348,790
Creditors amounts falling due within one year8(660,305)(691,821)
Net current assets (liabilities)1,096,7621,656,969
Total assets less current liabilities1,130,1731,704,967
Creditors amounts falling due after one year9-(6,367)
Net assets1,130,1731,698,600
Capital and reserves
Called up share capital33
Share premium6,789,6805,296,280
Profit and loss account(5,659,510)(3,597,683)
Shareholders' funds1,130,1731,698,600
The financial statements were approved and authorised for issue by the Board of Directors on 30 September 2026, and are signed on its behalf by:
FORTE, Irene Alisea
Director
Registered Company No. 10941882
FORTE ORGANICS LTD
Notes to the Financial Statements
for the year ended 31 December 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Plant and machinery3
Office Equipment3
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
2.Average number of employees

20252024
Average number of employees during the year76
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 January 25166,878166,878
At 31 December 25166,878166,878
Amortisation and impairment
At 01 January 25141,619141,619
Charge for year15,21015,210
At 31 December 25156,829156,829
Net book value
At 31 December 2510,04910,049
At 31 December 2425,25925,259
4.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 01 January 252,874-2,874
Additions1,0858831,968
At 31 December 253,9598834,842
Depreciation and impairment
At 01 January 25908-908
Charge for year1,1002451,345
At 31 December 252,0082452,253
Net book value
At 31 December 251,9516382,589
At 31 December 241,966-1,966
5.Fixed asset investments

Investments in groups1

Total

££
Cost or valuation
At 01 January 2520,77320,773
At 31 December 2520,77320,773
Net book value
At 31 December 2520,77320,773
At 31 December 2420,77320,773

Notes

1Investments in group undertakings and participating interests
6.Stocks

2025

2024

££
Finished goods722,731905,803
Other stocks141,972152,217
Total864,7031,058,020
7.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables621,385400,272
Amounts owed by group undertakings100,45475,340
Other debtors26,60571,915
Prepayments and accrued income38,03147,444
Total786,475594,971
8.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables453,498382,877
Bank borrowings and overdrafts6,4907,367
Taxation and social security99,32432,392
Other creditors4,713210,955
Accrued liabilities and deferred income96,28058,230
Total660,305691,821
9.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts-6,367
Total-6,367
10.Events after reporting date
After the reporting date, the company received c.£1.5 million from investors under advance subscription agreements, which will convert into shares at a future date. This is a non-adjusting event and has not been reflected in these financial statements.
11.Related party transactions
Barry Jones, a director and shareholder of the company, had made an unsecured loan to the company. At 31 December 2024 the amount outstanding was £208,810 (2023: £207,279), included within creditors. On 2 May 2025 the loan balance of £208,192 was settled in full by the issue of 561 ordinary shares of £0.0001 each at a premium, as part of the share issue completed on that date. No amount was outstanding at 31 December 2025. Interest of £2,097 (2024: £1,531) was charged on the loan up to the date of conversion. During the year the company paid rent of £25,824 (2024: £19,881) to Barry Jones for office premises provided to the company. No amount was outstanding at 31 December 2025 (2024: £19,881 accrued, invoiced after the reporting date).
12.Controlling party
In the opinion of the directors, the company is not under the control of any single individual or entity.